Litigation for Patent RE44,186
✉ Email this page to a colleague
US Court Litigation for Patent: RE44,186
| Patent_nolink | Case Name | Docket | Date Filed | Date Terminated | Cause | Court | Jury Demand | Link To Docket |
|---|---|---|---|---|---|---|---|---|
| RE44186 | AstraZeneca AB v. Mylan Pharmaceuticals Inc. | 1:14-cv-00094|N.D.W. Va. | 2014-06-03 | 2017-03-10 | 35:145 Patent Infringement | District Court, N.D. West Virginia | None | ⤷ Start Trial |
| RE44186 | ⤷ Start Trial | 1:14-cv-00664|D. Del. | 2014-05-23 | 2017-02-02 | 35:271 Patent Infringement | District Court, D. Delaware | Defendant | ⤷ Start Trial |
| RE44186 | AstraZeneca AB v. Glenmark Generics Ltd. | 1:14-cv-00665|D. Del. | 2014-05-23 | 2015-04-14 | 35:271 Patent Infringement | District Court, D. Delaware | None | ⤷ Start Trial |
| RE44186 | AstraZeneca AB v. Watson Laboratories Inc. | 1:14-cv-00666|D. Del. | 2014-05-23 | 2015-04-16 | 35:271 Patent Infringement | District Court, D. Delaware | Defendant | ⤷ Start Trial |
| RE44186 | AstraZeneca AB v. Wockhardt Bio AG | 1:14-cv-00667|D. Del. | 2014-05-23 | 2017-02-02 | 35:271 Patent Infringement | District Court, D. Delaware | None | ⤷ Start Trial |
| RE44186 | ⤷ Start Trial | 1:14-cv-00694|D. Del. | 2014-06-02 | 2017-02-02 | 35:271 Patent Infringement | District Court, D. Delaware | None | ⤷ Start Trial |
| RE44186 | AstraZeneca AB v. Mylan Pharmaceuticals Inc. | 1:14-cv-00696|D. Del. | 2014-06-02 | 2017-02-02 | 35:271 Patent Infringement | District Court, D. Delaware | None | ⤷ Start Trial |
| >Patent_nolink | >Case Name | >Docket | >Date Filed | >Date Terminated | >Cause | >Court | >Jury Demand | >Link To Docket |
Patent Trial and Appeal Board Cases for Patent RE44,186
| Patent | Petitioner | Status | Filing Date | Accorded Filing Date | Patent Owner | Trial Type | Trial Number | Decision Date | Inventor | Document Download |
|---|---|---|---|---|---|---|---|---|---|---|
| RE44,186 | Mylan Pharmaceuticals Inc. | ⤷ Start Trial | 2015-06-04 | 06-04-2015 | AstraZeneca AB | Inter partes review | ⤷ Start Trial | 05-02-2016 | Jeffrey Robl | ⤷ Start Trial |
| RE44,186 | Wockhardt Bio AG | ⤷ Start Trial | 2016-05-11 | 05-11-2016 | AstraZeneca AB | Inter partes review | ⤷ Start Trial | 08-23-2016 | Jeffrey Robl | ⤷ Start Trial |
| RE44,186 | Amneal Pharmaceuticals LLC et al. | ⤷ Start Trial | 2016-06-01 | 06-03-2016 | AstraZeneca AB | Inter partes review | ⤷ Start Trial | 11-22-2016 | Jeffrey Robl | ⤷ Start Trial |
| RE44,186 | Aurobindo Pharma U.S.A., Inc. et al. | ⤷ Start Trial | 2016-06-02 | 06-02-2016 | ASTRAZENECA AB | Inter partes review | ⤷ Start Trial | 10-21-2016 | Jeffrey Robl | ⤷ Start Trial |
| RE44,186 | Teva Pharmaceuticals USA Inc. | ⤷ Start Trial | 2016-06-01 | 06-01-2016 | AstraZeneca AB | Inter partes review | ⤷ Start Trial | 09-23-2016 | Jeffrey Robl | ⤷ Start Trial |
| >Patent | >Petitioner | >Status | >Filing Date | >Accorded Filing Date | >Patent Owner | >Trial Type | >Trial Number | >Decision Date | >Inventor | >Document Download |
